Histiocytoses - large group of heterogenous disorders with evolving clinical and molecular classifications
- Age, comorbidities and systemic findings influence the clinical course
- Pediatric workup ruling out aggressive paraneoplastic outcomes is paramount
- Derived from a common CD34+ hematopoietic precursor
Histiocytes - descriptive term used in pathology for mononuclear phagocytes residing in tissues (histio=”tissue”, cyte “cell”). Includes tissue macrophage or a dendritic cell. Group of cells that represent the immune system for the skin, includes:
- Langerhans dendritic cell - antigen presenting cell (APC) for epidermis (LCH disorders)
- CD14 negative
- Langerhans Cell Histiocytosis (LCH)
- Dermal dendritic cell - antigen presenting cell (APC) for dermis (Non-LCH disorders)
- CD14 positive Non-Langerhans Cell Histiocytosis (Non-LCH)
- Macrophage - antigen presenting cell (APC) and phagocytes to and from dermis (granulomatous disorders)
Histiocytosis classification - new
- Langerhans Histiocytosis
- Cutaneous & mucocutaneous Histiocytosis
- Rosai-Dorfman
- Malignant
- Hemophagocytic lymphohistiocytosis & macrophage activation syndrome